On ECHEMI
Home > Drugs > Rectal cancer
Rectal cancer
Rectal cancer refers to cancer located between the dentate line and the junction of the sigmoid colon and rectum. It is one of the most common malignant tumors in the gastrointestinal tract. The main manifestations are dull abdominal pain and abdominal discomfort; when rectal cancer progresses to the late stage, there will be obvious lower abdominal pain. As the disease progresses and the tumor grows to a certain extent, the patient will experience systemic symptoms such as anemia and weight loss. Its incidence rate ranks third among malignant tumors in the world. In 2011, the incidence rate in my country was about 23/100,000, and the mortality rate was about 11/100,000, and it has been increasing year by year. However, the early colorectal symptoms are not obvious, and most patients are already in the late stage when diagnosed. The 5-year survival rate of such patients is less than 10%. More than 90% of the cases are over 40 years old. The incidence rate of colorectal cancer in men and women is similar worldwide, with men slightly higher than women.
  • Site of disease:

    intestinal
  • Infectious :

    Not contagious
  • Frequent population:

    Men over 40 years old
  • Related symptoms:

    Stool becomes thinner and shaped like a pencil Rectal pain Small amount of bleeding in the lower gastrointestinal tract Feeling of incomplete defecation Blood in the stool
  • Concurrent disease:

Related Drugs
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:

Yangtze River Pharmaceutical (Group) Co., Ltd.

Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.